TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. BIOSIMILARS MARKET, BY TYPE (USD BILLION)
6.1. Monoclonal Antibodies
6.2. Insulin
6.3. Erythropoietin
6.4. Growth Hormones
7. BIOSIMILARS MARKET, BY APPLICATION (USD BILLION)
7.1. Oncology
7.2. Diabetes
7.3. Autoimmune Diseases
7.4. Chronic Inflammatory Diseases
8. BIOSIMILARS MARKET, BY END USE (USD BILLION)
8.1. Hospitals
8.2. Clinics
8.3. Homecare
8.4. Research Institutions
9. BIOSIMILARS MARKET, BY MANUFACTURING PROCESS (USD BILLION)
9.1. Recombinant DNA Technology
9.2. Hybridoma Technology
9.3. Transgenic Technology
10. BIOSIMILARS MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Biosimilars Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Biosimilars Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Zydus Cadila
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Eli Lilly
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Samsung Bioepis
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. GSK
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. AbbVie
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Boehringer Ingelheim
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. Teva Pharmaceutical Industries
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. Celltrion
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Fresenius Kabi
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Amgen
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Reddy's Laboratories
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Mylan
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. Sandoz
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Pfizer
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. Novartis
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 7. US BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 8. US BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 9. US BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 10. US BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 11. US BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 18. EUROPE BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 19. EUROPE BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. GERMANY BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 23. GERMANY BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 24. GERMANY BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 25. GERMANY BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 27. UK BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 28. UK BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 29. UK BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 30. UK BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 31. UK BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. FRANCE BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 33. FRANCE BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 34. FRANCE BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 35. FRANCE BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 36. FRANCE BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 37. RUSSIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 38. RUSSIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 39. RUSSIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 40. RUSSIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 41. RUSSIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. ITALY BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 43. ITALY BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 44. ITALY BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 45. ITALY BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 46. ITALY BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 47. SPAIN BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 48. SPAIN BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 49. SPAIN BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 50. SPAIN BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 51. SPAIN BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 52. REST OF EUROPE BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 53. REST OF EUROPE BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 54. REST OF EUROPE BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 55. REST OF EUROPE BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 56. REST OF EUROPE BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 57. APAC BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 58. APAC BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 59. APAC BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 60. APAC BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 61. APAC BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. CHINA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 63. CHINA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 64. CHINA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 65. CHINA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 66. CHINA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 67. INDIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 68. INDIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 69. INDIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 70. INDIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 71. INDIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 72. JAPAN BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 73. JAPAN BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 74. JAPAN BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 75. JAPAN BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 76. JAPAN BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 77. SOUTH KOREA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 78. SOUTH KOREA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 79. SOUTH KOREA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 80. SOUTH KOREA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 81. SOUTH KOREA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. MALAYSIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 83. MALAYSIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 84. MALAYSIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 85. MALAYSIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 86. MALAYSIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 87. THAILAND BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 88. THAILAND BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 89. THAILAND BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 90. THAILAND BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 91. THAILAND BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. INDONESIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 93. INDONESIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 94. INDONESIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 95. INDONESIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 96. INDONESIA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 97. REST OF APAC BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF APAC BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF APAC BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF APAC BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF APAC BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. SOUTH AMERICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 103. SOUTH AMERICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 104. SOUTH AMERICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 105. SOUTH AMERICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 106. SOUTH AMERICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 107. BRAZIL BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 108. BRAZIL BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 109. BRAZIL BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 110. BRAZIL BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 111. BRAZIL BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 112. MEXICO BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 113. MEXICO BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 114. MEXICO BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 115. MEXICO BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 116. MEXICO BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 117. ARGENTINA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 118. ARGENTINA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 119. ARGENTINA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 120. ARGENTINA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 121. ARGENTINA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 127. MEA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 128. MEA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 129. MEA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 130. MEA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 131. MEA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 132. GCC COUNTRIES BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 133. GCC COUNTRIES BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 134. GCC COUNTRIES BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 135. GCC COUNTRIES BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 136. GCC COUNTRIES BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 137. SOUTH AFRICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 138. SOUTH AFRICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 139. SOUTH AFRICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 140. SOUTH AFRICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 141. SOUTH AFRICA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 142. REST OF MEA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 143. REST OF MEA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 144. REST OF MEA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 145. REST OF MEA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY MANUFACTURING PROCESS, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF MEA BIOSIMILARS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA BIOSIMILARS MARKET ANALYSIS
FIGURE 3. US BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 4. US BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 5. US BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 6. US BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 7. US BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 9. CANADA BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 10. CANADA BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 11. CANADA BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 12. CANADA BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE BIOSIMILARS MARKET ANALYSIS
FIGURE 14. GERMANY BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 15. GERMANY BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 16. GERMANY BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 17. GERMANY BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 18. GERMANY BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 20. UK BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 21. UK BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 22. UK BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 23. UK BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 25. FRANCE BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 26. FRANCE BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 27. FRANCE BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 28. FRANCE BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 30. RUSSIA BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 31. RUSSIA BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 32. RUSSIA BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 33. RUSSIA BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 35. ITALY BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 36. ITALY BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 37. ITALY BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 38. ITALY BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 40. SPAIN BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 41. SPAIN BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 42. SPAIN BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 43. SPAIN BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 45. REST OF EUROPE BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 46. REST OF EUROPE BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 47. REST OF EUROPE BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 48. REST OF EUROPE BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC BIOSIMILARS MARKET ANALYSIS
FIGURE 50. CHINA BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 51. CHINA BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 52. CHINA BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 53. CHINA BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 54. CHINA BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 56. INDIA BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 57. INDIA BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 58. INDIA BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 59. INDIA BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 61. JAPAN BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 62. JAPAN BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 63. JAPAN BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 64. JAPAN BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 66. SOUTH KOREA BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 67. SOUTH KOREA BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 68. SOUTH KOREA BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 69. SOUTH KOREA BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 71. MALAYSIA BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 72. MALAYSIA BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 73. MALAYSIA BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 74. MALAYSIA BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 76. THAILAND BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 77. THAILAND BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 78. THAILAND BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 79. THAILAND BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 81. INDONESIA BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 82. INDONESIA BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 83. INDONESIA BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 84. INDONESIA BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 86. REST OF APAC BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 87. REST OF APAC BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 88. REST OF APAC BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 89. REST OF APAC BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA BIOSIMILARS MARKET ANALYSIS
FIGURE 91. BRAZIL BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 92. BRAZIL BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 93. BRAZIL BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 94. BRAZIL BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 95. BRAZIL BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 97. MEXICO BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 98. MEXICO BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 99. MEXICO BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 100. MEXICO BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 102. ARGENTINA BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 103. ARGENTINA BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 104. ARGENTINA BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 105. ARGENTINA BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 107. REST OF SOUTH AMERICA BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 108. REST OF SOUTH AMERICA BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 109. REST OF SOUTH AMERICA BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 110. REST OF SOUTH AMERICA BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA BIOSIMILARS MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 113. GCC COUNTRIES BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 114. GCC COUNTRIES BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 115. GCC COUNTRIES BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 116. GCC COUNTRIES BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 118. SOUTH AFRICA BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 119. SOUTH AFRICA BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 120. SOUTH AFRICA BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 121. SOUTH AFRICA BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA BIOSIMILARS MARKET ANALYSIS BY TYPE
FIGURE 123. REST OF MEA BIOSIMILARS MARKET ANALYSIS BY APPLICATION
FIGURE 124. REST OF MEA BIOSIMILARS MARKET ANALYSIS BY END USE
FIGURE 125. REST OF MEA BIOSIMILARS MARKET ANALYSIS BY MANUFACTURING PROCESS
FIGURE 126. REST OF MEA BIOSIMILARS MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF BIOSIMILARS MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF BIOSIMILARS MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: BIOSIMILARS MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: BIOSIMILARS MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: BIOSIMILARS MARKET
FIGURE 133. BIOSIMILARS MARKET, BY TYPE, 2024 (% SHARE)
FIGURE 134. BIOSIMILARS MARKET, BY TYPE, 2019 TO 2032 (USD Billions)
FIGURE 135. BIOSIMILARS MARKET, BY APPLICATION, 2024 (% SHARE)
FIGURE 136. BIOSIMILARS MARKET, BY APPLICATION, 2019 TO 2032 (USD Billions)
FIGURE 137. BIOSIMILARS MARKET, BY END USE, 2024 (% SHARE)
FIGURE 138. BIOSIMILARS MARKET, BY END USE, 2019 TO 2032 (USD Billions)
FIGURE 139. BIOSIMILARS MARKET, BY MANUFACTURING PROCESS, 2024 (% SHARE)
FIGURE 140. BIOSIMILARS MARKET, BY MANUFACTURING PROCESS, 2019 TO 2032 (USD Billions)
FIGURE 141. BIOSIMILARS MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 142. BIOSIMILARS MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS
